http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110638798-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C37-68 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C37-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
filingDate | 2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110638798-B |
titleOfInvention | Use of alkylresorcinols in the preparation of a product for preventing or treating obesity-related diseases |
abstract | The invention belongs to the technical field of weight-losing products, and particularly relates to application of alkylresorcinol in preparation of products for preventing or treating obesity-related diseases. Use of alkylresorcinol in the manufacture of a product for the prevention and/or treatment of obesity related diseases and for increasing energy metabolism and body heat production, characterized in that the product comprises as active ingredient alkylresorcinol consisting of the following monomers in weight percent: 1-10% of heptadecyl resorcinol; nonadecyl resorcinol 20-25%; 50-55% of heneicosyl resorcinol; 5-10% of eicosatriylresorcinol; 5-12% of pentacosyl resorcinol. The invention defines the proper proportion of the corresponding monomers when the alkylresorcinol plays a role in preventing or treating obesity by improving the energy metabolism or the heat production of an organism. |
priorityDate | 2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.